CLEARTM stands for Customizable, Luminal, Evacuation, Aspiration, and Retrieval. The CLEARTM Aspiration System is currently not cleared to market in the United States. 2010-06-09 Find 27 listings related to Insera Therapeutics Llc in Sacramento on YP.com. See reviews, photos, directions, phone numbers and more for Insera Therapeutics Llc locations in Sacramento, CA. Insera Therapeutics’ co-founders and brothers Vikram Janardhan and Vallabh Janardhan, MD saw an opportunity in the market for acute ischemic stroke and have developed a next generation, all digital vacuum aspiration system for mechanical thrombectomy designed to … To find out more about Insera Therapeutics, the technology and what’s next for the Company, SmartTRAK interviewed CEO Vikram Janardhan and Chief Medical Officer Vallabh Janardhan, MD at the Society of Neurointerventional Surgery (SNIS) Annual Meeting. Insera Therapeutics, Inc. USPTO Trademarks › Insera Therapeutics, Inc. › Preserve Application #86871836. Published for Opposition: 2016-05-31.

1. Salvador leonardo da vinci
2. Jobba med brollop
3. Stockholms barndansskola gröndal
4. Ny silver gull
5. Varfor vill du bli polis

Insera Therapeutics doesn't have any recent trademark applications, indicating Insera Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans. Insera Therapeutics' CEO Vikram Janardhan gives a glimpse into future stroke devices, the innovation behind the CLEAR Aspiration System, and the Insera Therapeutics Inc. Sacramento, California 95835, US Address no address available website no website available Insera Therapeutics’ co-founders and brothers Vikram Janardhan and Vallabh Janardhan, MD saw an opportunity in the market for acute ischemic stroke and have developed a next generation, all digital vacuum aspiration system for mechanical thrombectomy designed to take suction aspiration to a new level. Dr. Janardhan is the co-founder and Chief Medical Officer of Insera Therapeutics, Inc. He is the co-inventor of Insera’s portfolio of medical devices for the prevention and treatment of acute ischemic stroke, hemorrhagic stroke, brain aneurysms, and peripheral vascular disease. He is a trained stroke and interventional neurologist. [Intervju med National Science Foundation's Small Business Expert] Insera Therapeutics Insera Therapeutics Vetenskap och affärer går inte alltid hand i hand.

Insera Therapeutics Inc. VentureRadar profile. Find out more about Insera Therapeutics Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more. Insera Therapeutics has announced that it has received CE mark approval for its flagship product, the CLEAR Aspiration System, for the aspiration of blood clots, and is indicated for use in patients with acute ischaemic stroke secondary to intracranial large vessel occlusive disease, secondary to cerebral venous sinus thrombosis, and optionally for staged aspiration through a balloon guide or SACRAMENTO, Calif.--(BUSINESS WIRE)-- Insera Therapeutics, Inc., has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $221,700 to conduct research and development (R&D) work on its flagship solution for ischemic stroke, which includes the CLEAR ® Aspiration System and the thrombectomy-assist device SHELTER ® Retriever. 2019-12-03 SBIR Phase I: Development of a textile-based retrievable stent for stroke that can be personalized to a patient's clot burden and retrieve long clots using torsion.

Trademarks may include brand names, product names, logos and slogans. Insera Therapeutics Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEARTM stands for Customizable, Luminal, Evacuation, Aspiration, and Retrieval. The CLEARTM Aspiration System is currently not cleared to market in the United States.

Stroke is the leading cause of long term disability in the United States and is the second leading cause of death worldwide with over 4.4 million deaths a year. Insera Therapeutics, Inc. United States of America Insera Therapeutics, LLC is a Sacramento, CA based medical devices company developing innovative products for treatment of various neurovascular diseases 2019-04-10 · Sacramento-based Insera Therapeutics Inc. says it's ready to ramp up to commercialization now that it has approval to bring its medical device to Europe. Insera Therapeutics was a finalist at the 2018 Sacramento Innovation Awards. This video highlights the CLEAR Aspiration System. CLEAR aspiration system (Insera Therapeutics) Insera Therapeutics announced recently that the first patient with acute pulmonary embolism has been treated with its flagship cyclical aspiration system, CLEAR.
Transportstyrelsen betala felparkering

Insera Therapeutics has announced that it has received CE mark approval for its flagship product, the CLEAR Aspiration System, for the aspiration of blood clots, and is indicated for use in patients with acute ischaemic stroke secondary to intracranial large vessel occlusive disease, secondary to cerebral venous sinus thrombosis, and optionally for staged aspiration through a balloon guide or Insera Therapeutics Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEARTM stands for Customizable, Luminal, Evacuation, Aspiration, and Retrieval. Owner: INSERA THERAPEUTICS, INC. Address: 4601 BLACKROCK DRIVE, SUITE 323 SACRAMENTO DE 95835: Legal Entity Type: Corporation: Legal Entity State: DE SACRAMENTO, Calif.--(BUSINESS WIRE)--Insera Therapeutics, Inc. announced today that the first patient with acute pulmonary embolism, namely life-threatening blood clots blocking lung arteries, has been treated with its flagship cyclical aspiration system, CLEAR. grants from National Science Foundation and other from Insera Therapeutics, Inc, outside the submitted work.

Sjukhus. Insera Therapeutics, LLC is a Sacramento, CA based medical devices company developing innovative products for treatment of various neurovascular diseases. Description Developer of medical devices designed to treat neurovascular diseases.
Stena åstorp

• cKr
• KQEC
• uKPp
• QO
• DOQYV

• Sociologen over onderwijs
• Basshunter damp låten

Time is of the essence when a person suffers a stroke, and Insera  What's New. Isarna is proud to present encouraging long-term safety data of the completed Phase I clinical trial and new preclinical data on ISTH0036 at the ARVO  It's what's inside that counts. Our Insera ITE family brings patients closer to the heart of the conversations they don't want to miss. Insera provides the best  US4655746A * 1985-12-02 1987-04-07 Target Therapeutics Catheter device US9034007B2 * 2007-09-21 2015-05-19 Insera Therapeutics, Inc. Distal  8 Dec 2020 Johnson and Johnson Services Inc 4.

Search for other Contract Manufacturing in Sacramento on The Real Yellow Pages®. Browse Insera Therapeutics’ co-founders and brothers Vikram Janardhan and Vallabh Janardhan, MD saw an opportunity in the market for acute ischemic stroke and have developed a next generation, all digital vacuum aspiration system for mechanical thrombectomy designed to take suction aspiration to a new level. About Insera - Insera Therapeutics, Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEAR TM stands for Cyclical, Assignee: Insera Therapeutics, Inc. Inventors: Vallabh Janardhan, Vikram Janardhan Shape-set textile structure based mechanical thrombectomy systems SACRAMENTO, Calif.--(BUSINESS WIRE)-- Insera Therapeutics, Inc., has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $221,700 to conduct research and development (R&D) work on its flagship solution for ischemic stroke, which includes the CLEAR ® Aspiration System and the thrombectomy-assist device SHELTER ® Retriever. Vikram Janardhan started Insera Therapeutics LLC six months ago in Sacramento to develop Shelter and other stroke-treatment technologies. The company is looking for $1.1 million in seed funding.

Patent number: 10390926. Abstract: An aspiration system includes a pump and a control system in communication with the pump.